- Home
- PROK vs WNEB Comparison
PROK vs WNEB Comparison
Compare PROK & WNEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PROK | WNEB |
|---|---|---|
| Founded | 2015 | 1853 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 316.0M | 264.8M |
| IPO Year | 2021 | 2001 |
Fundamental Metrics
Financial Performance| Metric | PROK | WNEB |
|---|---|---|
| Price | $1.41 | $14.05 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 3 |
| Target Price | $7.40 | ★ $13.67 |
| AVG Volume (30 Days) | ★ 1.0M | 48.2K |
| Earning Date | 05-08-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 2.00% |
| EPS Growth | N/A | ★ 33.93 |
| EPS | N/A | ★ 0.42 |
| Revenue | ★ $893,000.00 | $44,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $7.25 |
| P/E Ratio | ★ N/A | $33.48 |
| Revenue Growth | ★ 1075.00 | N/A |
| 52 Week Low | $1.41 | $10.78 |
| 52 Week High | $3.48 | $15.01 |
Technical Indicators
Market Signals| Indicator | PROK | WNEB |
|---|---|---|
| Relative Strength Index (RSI) | 34.85 | 51.68 |
| Support Level | N/A | $13.33 |
| Resistance Level | $2.59 | $14.24 |
| Average True Range (ATR) | 0.09 | 0.58 |
| MACD | -0.00 | 0.03 |
| Stochastic Oscillator | 0.03 | 58.89 |
Price Performance
Historical ComparisonAbout PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company pioneering the development of a first-in-class, autologous cell therapy that is intended to preserve kidney function in patients with advance chronic kidney disease (CKD) and diabetes. Its product candidate, REACT (Renal Autologous Cell Therapy), is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
About WNEB Western New England Bancorp Inc.
Western New England Bancorp Inc through its bank subsidiary, provides a range of financial services to individuals and companies in western Massachusetts and northern Connecticut. These services include commercial lending, residential lending and consumer lending, checking, savings and time deposits, cash management, and wealth management. Substantially all of the company's revenues, profits, and assets are derived by the Bank from banking products and services.